Resources

Quotient Sciences announced the installation of Centillion’s™ proprietary Biofoundry-in-a-Box (BiaB™), a modular, integrated, and automated RNA-micro factory which enables the end-to-end production of various RNA-based products.

Pension reform unlocks cash for UK life sciences, London Life Sciences Week and #bioProcessUK are here.

Aravax, a clinical-stage biotechnology company developing next-generation immunotherapies designed to be safe, convenient, and precisely targeted, today announces it has established a UK subsidiary, based on the Oxford Science Park, as the company continues its development into an international leader in food allergies.

Facility dedicated to cryopreservation of leukapheresis starting materials to support clinical and commercial cell-based therapy programs

New data shows investing in life sciences produces great returns, London Life Sciences Week and #bioProcessUK are nearly here.

Astex Pharmaceuticals announced today that it will make five key data presentations at the 36th EORTC-NCI-AACR Symposium on molecular targets and cancer therapeutics, 23rd-25th October 2024, Barcelona, Spain.

Optibrium today announced the publication of a peer-reviewed study in the Journal of Computer-Aided Molecular Design

tranScrip is delighted to announce the appointment of Roz Sutton as Senior Director of Regulatory Affairs

We are delighted to announce that Dr. Kathryn (Kate) Owen has joined tranScrip as Executive Medical Director in our Early Development Group.

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies.

Symbiosis Pharmaceutical Services Ltd announces the purchase of new premises in Stirling, Scotland, UK. The additional space will double the total footprint of the company across the four facilities that it will operate from, increasing manufacturing capacity by 50% in the short-term.

Ingenza, a world-leading contract research, development and manufacturing organisation (CRDMO) and technology accelerator, has signed a 10-year lease at the Moubray Building at Edinburgh Technopole, part of Pioneer Group.

The BioIndustry Association, in partnership with the CPI, is today publishing a new report - mRNA Revolution: A new generation of medicine. 

Quell Therapeutics expands manufacturing capabilities for CAR-Treg cell therapy pipeline through partnership with eXmoor pharma. The multi-year agreement focuses on the manufacture of multiple CAR-Treg product candidates for Phase 1/2 clinical studies.

In a ground-breaking collaboration, leading biotechnology companies and research organizations in the UK and Canada are entering into an R&D project jointly funded by a £1.1 million grant from Innovate UK (part of UK Research and Innovation) and the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).

FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses, today hosted a celebration for the opening of its microbial fermentation manufacturing facility in Billingham.

Connect with Fellow Leaders Shaping Cell and Gene Therapy Development